Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.
A Texas A&M AgriLife Research study has led to the discovery of the first curative and preventive bacteriophage treatment against the pathogen Xylella fastidiosa, which causes the deadly Pierce’s disease in grapevines.
The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients.
A study from the Center for Phage Technology, part of Texas A&M’s College of Agriculture and Life Sciences and Texas A&M AgriLife Research, shows how the “hidden” genes in bacteriophages — types of viruses that infect and destroy bacteria — may be key to the development of a new class of antibiotics for human health.